Risk of respiratory depression with opioids and concomitant gabapentinoids
Julie Savelloni,1 Heather Gunter,2 Kelly C Lee,3 Chih Hsu,1 Cassia Yi,2 Kyle P Edmonds,4 Timothy Furnish,5 Rabia S Atayee1 1Department of Pharmacy, UC San Diego Health, San Diego, CA, USA; 2Department of Nursing, UC San Diego Health, San Diego, CA, USA; 3Skaggs School of Pharmacy and Pharmaceutical...
Main Authors: | Savelloni J, Gunter H, Lee KC, Hsu C, Yi C, Edmonds KP, Furnish T, Atayee RS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-11-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/risk-of-respiratory-depression-with-opioids-and-concomitant-gabapentin-peer-reviewed-article-JPR |
Similar Items
-
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
by: Desai, P.H, et al.
Published: (2021) -
Risk of respiratory depression with opioids and concomitant gabapentinoids [Corrigendum]
by: Savelloni J, et al.
Published: (2018-09-01) -
Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
by: Jørn Henrik Vold, et al.
Published: (2020-04-01) -
Gabapentinoid prescription in Oral Medicine and Oral Surgery practice. Part II − a systematic scoping review of the literature
by: Sulukdjian Arek, et al.
Published: (2020-01-01) -
Gabapentinoid prescription in oral medicine and oral surgery practice. Part I − Experience from a French Orofacial pain clinic
by: Sulukdjian Arek, et al.
Published: (2020-01-01)